Stock Updates

How has GlaxoSmithKline plc:(NYSE:GSK) performed recently?

GlaxoSmithKline plc (NYSE: GSK) is a large market cap stock with a market cap of 108218.67. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 3110, a forward P/E of 15.68 and EPS of 0.01. At a stock price of 43.54 (0.90%) it has a dividend yield of 5.05%.

EPS growth for the last five years have been 40.20%, more recently this last year it has grown by 204.10%. The next year growth is going to be about 6.52% and more long-term 10.00% after five years. EPS growth quarter over quarter is -392.80%. Sales growth for the past five years have been -3.40% and sales growth quarter over quarter is 10.90%.

For performance, GlaxoSmithKline plc the past week has seen a gain of -0.25%. For the last month performance for GlaxoSmithKline plc is -1.76%. While the last quarter is 8.54% and half year, 9.50%. Finally for the year, performance is 15.22%.

The 52-week high for GlaxoSmithKline plc, is at -3.39%, and for the 52-week low it comes to a value of 25.37%. The 20-day simple moving average is -0.55% and 7.02% for the 200-day simple moving average.

Volatility for the week is at 1.45%, and for the month it is 1.03%. GlaxoSmithKline plc, has a target price of 48.67.

In terms of debt, long term debt/equity is 26.3, and for total debt/equity GlaxoSmithKline plc has 34.12. The gross margin is 66.60%, while operating margin is 5.30%, the profit margin is 0.10%. The current ratio is 0.9 and the quick ratio is 0.6.

Insider ownership is at 0.20%, with instituitional ownership at 9.10%. GlaxoSmithKline plc has a payout ratio of *TBA. With the total shares outstanding coming to 2485.5. The shares float is 2416.83, with the float short at 0.32%, with short ratio coming to 2.42.

In terms of returns, the return on assets see GlaxoSmithKline plc, get 0.10%, with its returns on investment at 41.40%. Return on equity is 0.90%. So will the investors see the target price of 48.67, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment